"The design of nonpeptide systems that are able to imitate some of the functions and structures of α-helices, but with more desirable drug-like properties is an area of intense investigation."
Many traditional anticancer agents act by damaging cellular DNA, but the lack of selectivity offered by this approach commonly leads to undesirable side effects [1] . In addition, the genetic instability of cancer cells facilitates the development of resistance to particular drug pathways [2] . There is thus a drive to discover systems that exhibit different -perhaps more subtle -modes of action. Host defense peptides, which are expected to act by prohibiting cellular processes through reversible and selective biomolecular interactions, have been investigated as potential anticancer agents to this aim [3] . However, these innate proteins are not ideal drug candidates as, although their pharmacodynamic profiles are promising, they tend to suffer from poor pharmacokinetics [4] . The design of nonpeptide systems that are able to imitate some of the functions and structures of α-helices, but with more desirable drug-like properties is an area of intense investigation [5] . Such peptidomimetics could nevertheless be as costly and difficult to synthesize as peptides [6] , and they commonly have low solubility in aqueous media [7] . In addition, the exquisite 3D architecture of the α-helix is difficult to achieve realistically using the rather flat topographies of conventional synthetic organic chemistry.
Helicates: a problem of stereochemistry, functionality & stability Helicates -assemblies of rigid organic ligands around a metal ion core -resemble α-helices in terms of their diameter and charge [8] . The idea that metallohelices may function as peptidomimetics -including synthetic and biophysical studies of their potential in the biological regime -has been advanced by groups worldwide [9] . Until recently, however, these studies have been limited to rather few compounds. Hannon and colleagues reported a DNA-binding iron(II) helicate with antimicrobial [10] and anticancer [11] activity. An arginine-decorated analog showed slightly higher cytotoxicity than the parent compound against A2780 ovarian cancer cells (IC 50 : ∼7 μM) [12] . The parent helicate is of a comparable size to a key α-helical motif of the amyloid-β peptide, a therapeutic target in Alzheimer's disease [13] . Qu has discovered that this indeed strongly binds to the protein and inhibits its aggregation [13] . The interaction appears to reduce the cytotoxicity of amyloid-β in PC12 rat pheochromocytoma cells; treatment with the helicate alone did not affect cell viability. In vivo studies showed that the compound ameliorated memory deficits in a transgenic mouse model [13] .
Certainly helicates have provided some preliminary results in these early phenotypic studies, but can they become realistic drug candidates? They are not like anything in the clinic, which is at once exciting and worrying. They are 'small' molecules rather than 'biologicals', but actually are assembled from a collection of small-molecule subunits, and the application of Lipinski's rule of five would seem rather naive. Nevertheless, in order to move towards serious preclinical studies, a number of practical criteria must be achieved. These criteria are common to all synthetic drugs, but in our view, not enough attention has been Editorial Kaner & Scott paid to this in helicate chemistry. The compounds must be: optically pure and nonracemizing for use in human systems; soluble and stable in aqueous solutions; readily available on a practical scale; and synthetically flexible so that properties can be optimized [14] .
These are rather stringent targets for coordination chemistry, where, for example, the art of enantioselective synthesis lags far behind that of carbon chemistry and functionalized complexes are rather rare. In order to make structurally robust complexes, it is conventional to use inert metal ions, such as ruthenium(II). Aside from the inherent toxicity, this causes a synthetic problem for helicates, in that kinetic mixtures of complexes are always formed. Laborious separations are then necessary, leading to poor chemical yields [15] . Furthermore, in order to reduce the number of possible isomers formed, helicate self-assembly uses highly symmetrical building blocks. Hence, the idea of the deliberate placement of α-helix mimetic recognition elements might seem rather fanciful. Nevertheless, recent reports have moved us significantly closer to realizing the above targets.
Optically pure, functionalized & more stable metallohelices We first addressed the problems of optical purity, synthetic flexibility and stability in water. Our strategy for metallohelix self-assembly was inspired by Lehn et al. [8] , but does not rely on the use of rigid ligands. The key was the development of simple self-assembling, optically pure monometallic complexes utilizing amino acid derivatives as the source of chirality [16] . These complexes were connected together with linear linkers to form helical bimetallic species known as 'flexicates' [17] . The compounds are readily water soluble and remarkably stable in a variety of media.
Promising antimicrobial activity of certain flexicates was observed towards methicillin-resistant Staphylococcus aureus and Escherichia coli, alongside low toxicity to the nonmammalian model organism Caenorhabditis elegans [17] . Studies on protein mimetic-protein interactions by Qu and colleagues indicate that one flexicate enantioselectively inhibits amyloid-β through targeting α/β-discordant stretches at the early steps of aggregation, with this being the first time such an observation has been made [18] . This is demonstrated using fluorescent living cell-based screening and multiple biophysical and biochemical approaches.
DNA interaction studies showed the selectivity of some compounds for 5´-CACATA and 5´-CACTAT segments, as well as for stabilizing different three-and four-way oligonucleotide junctions [19] . Enantiomer effects were also noted, and Λ Fe enantiomers were found to be the stronger DNA binders. Other flexicates show no affinity for DNA, but are found to be active in ovarian cancer (IC 50 : ∼3.5 μM in A2780 ovarian cancer cells) [19] . Flexicates do not damage DNA in cancerous cells like many traditional agents, but act by inducing cell cycle arrest and apoptosis. They show high activity in the habitually resistant cell line A2780cis (cisplatin-resistant ovarian carcinoma) [19] .
While flexicates have very favorable properties and display structure-dependent activity in various phenotypic screens, they are rather symmetrical and do not provide the kind of topographies that can realistically be described as peptidomimetic. As Albrecht has noted, "…the development of a synthetic route to asymmetric helicates … would create significantly more freedom for tailoring the structure -which, for instance, could enable the optimization of biological properties" [20] . We have recently disclosed that low-symmetry systems, which we call 'triplex metallohelices', are available [21] . The desirable properties of the flexicate series are retained, or indeed amplified, and the triplex architectures were found to be chemically and enantiomerically very stable in water and various biological media. Crucially, the topographies presented are amphipathic, in that they feature a hydrophobic face opposite a region that may be functionalized with a range of polar recognition elements. The structures are thus far more reminiscent of short peptidic α-helices [3] . Examples of these triplex metallohelices were highly active against colon cancer cell lines, but with lower activity against others, and showed essentially no activity against bacteria. This kind of selectivity is very unusual and indicates a subtle biomimetic mechanism. Dramatic effects on the cell cycle and the promotion of early apoptosis were observed, but no DNA damage was detected in a range of studies [21] .
Vázquez has recently reported an approach to asymmetric helicate synthesis using a single optically pure ligand from solid-phase synthesis containing two hairpin turns that -according to calculations -predisposes the formation of a bimetallic iron(II) helix [23] . The complex is assembled in situ on a small scale and is not isolated, but is detected by mass spectrometry. The isomeric purity was investigated by circular dichroism, but this merely shows that there is an enantiomeric excess of one helicity [22] . In this preliminary communication, it was suggested that the helical complex may bind to DNA, and there is evidence that it accessed the intracellular environment of Vero cells [23] .
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The chemistry underpinning these new approaches will allow for much greater diversity in functionality and structure than has been possible hitherto in the general area of helicates, but there is a need for still greater structural and synthetic diversity. The ability to place functional groups at positions of choice in helicates to the degree that nature manages with peptidic systems is still a few steps away.
Translation to the clinic?
It should be noted that the metallohelices described here exist exclusively in their helical state (i.e., there is not a detectable unfolded architecture until irreversible hydrolysis eventually occurs). While this is advantageous in terms of equilibrium binding to α-helix recognition sites, we must be realistic regarding stability in aqueous systems. With the exception of a few systems, there is currently little information on this in the literature [17, 21] .
A significant amount of preliminary work on biological activity is available, but this must be built upon with more detailed mechanistic studies towards translation to the clinic. Quite appropriately, the work so far has been based on phenotypic screening, asking the simple question: do these metallohelices behave like short antimicrobial/anticancer peptides? We feel that the early focus in this area on DNA binding was perhaps rather opportunistic -such phenomena are rather easy to study in a cell-free environment, and there is little if any evidence that the compounds pass through the cell membrane. The potentially more fruitful field of protein interactions needs far greater attention. A wider exploration of disease areas is also warranted, and the work of Qu and colleagues provides excellent examples [13, 18] . Furthermore, few selectivity (as opposed to mere activity) data have been presented for anticancer metallohelices, either in terms of differential activity between cancer cell lines [19] or organisms [21] .
It is nearly 30 years since Lehn et al. posited the idea that helicates bore a resemblance to natural α-helices [8] , but it is only recently that they have been approaching the point at which they may be considered to be α-helix mimetic. The chirality, stability and functionality of the latest systems, alongside their potency and selectivity against cancer cells, encourages us to be hopeful that this will be achieved, and that they might be translated to a clinical situation in this or other disease areas in which natural host defense peptides are known to play a role. No writing assistance was utilized in the production of this manuscript.
